Literature DB >> 12798048

Dynamics of bacterial colonisation in the respiratory tract of patients with cystic fibrosis.

N Renders1, H Verbrugh, A Van Belkum.   

Abstract

Mutations in the human genome may result in altered phenotypes. The cystic fibrosis (CF) patient, for instance, suffers from an aberrant composition of the epithelial lining of the gastrointestinal and respiratory tract. In this particular case, a single point mutation in the cystic fibrosis conductance regulator (CFTR) gene results in major physiological changes resulting in ecological changes that generate a niche particularly attractive to a selected set of microbial pathogens. We here present a review on the dynamics of the bacterial populations inhabiting the CF lung. Studies focusing on Staphylococcus aureus, Haemophilus influenzae and Pseudomonas aeruginosa will be summarised and discussed, whereas the technology used for microbial characterisation will be shortly highlighted. Emphasis, however, will be on those studies that assessed the genetic diversity among clinical isolates that were obtained over prolonged periods of time, enabling the distinction between persistent colonisation versus frequent re-infection by the selected pathogens. Evolutionary adaptation of pathogens to the CF lung is a common theme in many of these studies.

Entities:  

Mesh:

Year:  2001        PMID: 12798048     DOI: 10.1016/s1567-1348(01)00004-1

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  13 in total

Review 1.  Peptide signaling in the staphylococci.

Authors:  Matthew Thoendel; Jeffrey S Kavanaugh; Caralyn E Flack; Alexander R Horswill
Journal:  Chem Rev       Date:  2010-12-21       Impact factor: 60.622

Review 2.  Staphylococcal biofilms.

Authors:  M Otto
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

3.  Comparing the microbiota of the cystic fibrosis lung and human gut.

Authors:  Geraint B Rogers; Mary P Carroll; Lucas R Hoffman; Alan W Walker; David A Fine; Kenneth D Bruce
Journal:  Gut Microbes       Date:  2010-01-29

4.  Transcription of virulence factors in Staphylococcus aureus small-colony variants isolated from cystic fibrosis patients is influenced by SigB.

Authors:  Hélène Moisan; Eric Brouillette; Christian Lebeau Jacob; Philippe Langlois-Bégin; Sophie Michaud; François Malouin
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

5.  Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients.

Authors:  Rosa del Campo; María-Isabel Morosini; Elia Gómez-G de la Pedrosa; Asunción Fenoll; Carmen Muñoz-Almagro; Luis Máiz; Fernando Baquero; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

6.  Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations.

Authors:  María Carmen Turrientes; María Rosario Baquero; María Blanca Sánchez; Sylvia Valdezate; Esther Escudero; Gabrielle Berg; Rafael Cantón; Fernando Baquero; Juan Carlos Galán; José Luis Martínez
Journal:  Appl Environ Microbiol       Date:  2010-01-22       Impact factor: 4.792

7.  Chronic colonization with Pandoraea apista in cystic fibrosis patients determined by repetitive-element-sequence PCR.

Authors:  R M Atkinson; J J Lipuma; D B Rosenbluth; W M Dunne
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

8.  Nasal Staphylococcus aureus carriage is not a risk factor for lower-airway infection in young cystic fibrosis patients.

Authors:  Sabine Ridder-Schaphorn; Felix Ratjen; Angelika Dübbers; Johannes Häberle; Sabine Falk; Peter Küster; Antje Schuster; Uwe Mellies; Brigitte Löwe; Ralf Reintjes; Georg Peters; Barbara C Kahl
Journal:  J Clin Microbiol       Date:  2007-07-25       Impact factor: 5.948

9.  Biofilm Formation As a Response to Ecological Competition.

Authors:  Nuno M Oliveira; Nuno M Oliveria; Esteban Martinez-Garcia; Joao Xavier; William M Durham; Roberto Kolter; Wook Kim; Kevin R Foster
Journal:  PLoS Biol       Date:  2015-07-09       Impact factor: 8.029

10.  Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers.

Authors:  Henrique Douglas M Coutinho; Vivyanne S Falcão-Silva; Gregório Fernandes Gonçalves
Journal:  Int Arch Med       Date:  2008-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.